HI HR130

Urges the U.S. Food and Drug Administration to expedite approval of new nonprescription sunscreen active ingredients that are currently pending review through Time and Extent Applications submitted by the sunscreen industry

Notes that the United States has a limited number of approved nonprescription sunscreen active ingredients compared to globally available options that have demonstrated safe and effective use

States that as of the resolution's introduction date, the FDA had not approved any pending applications for new nonprescription sunscreen active ingredients despite their proven safety and effectiveness internationally

Requests that the FDA work collaboratively with stakeholders to approve ingredients that expand consumer access and choice in sunscreen products while enabling industry innovation

Directs transmission of certified copies to the U.S. Commissioner of Food and Drugs, congressional leadership, Hawaii's congressional delegation, and presiding officers of all state legislative bodies